SSTR2 and hepatocellular carcinoma: The analysis revealed that higher SSTR2 expression was significantly associated with poorer overall survival (OS) and disease-specific survival (DSS) in HCC patients (Figure 1B,C), suggesting that SSTR2 overexpression may have prognostic implications.